Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGLVI-20 (Immunoglobulin lambda variable (I)-20) is a pseudogene within the immunoglobulin lambda light chain variable region locus on human chromosome 22[3][5]. It is part of the family of genes responsible for the diversity of human antibody light chains but does not encode a functional protein due to its classification as a pseudogene. Functional variable region lambda genes are critical for antibody diversity and antigen recognition, but pseudogenes like IGLVI-20 contribute only indirectly through mechanisms such as gene conversion or recombination in some cases, though for most purposes, they are nonfunctional. "Immunoglobulin lambda variable" genes in general contribute to the specificity and diversity of the adaptive immune response, but IGLVI-20 itself does not encode a functional product and is not considered a therapeutic target[3][5]. Notable points: - The "immunoglobulin lambda variable" gene families include many variable gene segments; only a subset are functional, and IGLVI-20 is a pseudogene[2][5]. - As a pseudogene, IGLVI-20 is not referenced in the literature as a drug or therapeutic target, nor is it involved in known disease pathways or drug interactions[3][5]. - Confusion about targeting may arise from misreading the IG lambda locus, where only functional genes produce light chain proteins involved in B cell receptor and antibody formation[1][2]. - In structured databases and gene summaries, it is explicitly annotated as a pseudogene[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable (I)-20 (pseudogene) (IGLVI-20).